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Abstract Fecal microbiota transplantation (FMT) is an effective treatment for recurrent
Clostridium difficile infections (RCDIs). However, long-term effects on the patients’ gut
microbiota and the role of viruses remain to be elucidated. Here, we characterized
bacterial and viral microbiota in the feces of a cured RCDI patient at various time points
until 4.5 yr post-FMT compared with the stool donor. Feces were subjected to DNA
sequencing to characterize bacteria and double-stranded DNA (dsDNA) viruses including
phages. The patient’s microbial communities varied over time and showed little overall
similarity to the donor until 7 mo post-FMT, indicating ongoing gut microbiota adaption
in this time period. After 4.5 yr, the patient’s bacteria attained donor-like compositions at
phylum, class, and order levels with similar bacterial diversity. Differences in the bacterial
communities between donor and patient after 4.5 yr were seen at lower taxonomic levels.
C. difficile remained undetectable throughout the entire timespan. This demonstrated
sustainable donor feces engraftment and verified long-term therapeutic success of FMT
on the molecular level. Full engraftment apparently required longer than previously
acknowledged, suggesting the implementation of year-long patient follow-up periods
into clinical practice. The identified dsDNA viruses were mainly Caudovirales phages.
Unexpectedly, sequences related to giant algae–infecting Chlorella viruses were also
detected. Our findings indicate that intestinal viruses may be implicated in the
establishment of gut microbiota. Therefore, virome analyses should be included in gut
microbiota studies to determine the roles of phages and other viruses—such as Chlorella
viruses—in human health and disease, particularly during RCDI.
INTRODUCTION
Clostridium difficile is the leading cause of hospital-acquired infectious diarrhea (Lo Vecchio
and Zacur 2012). This bacterium capitalizes on antibiotic disruption of the normal microbiota
to colonize the intestine, causing disease mainly by secreted toxins (Lo Vecchio and Zacur
2012). Recent years have seen an increase in lethal C. difficile infections and the emergence
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of strains with increased toxin production and antibiotic resistance (McDonald et al. 2005;
Warny et al. 2005; Razavi et al. 2007; Lessa et al. 2012).
The failure of antibiotics to fully eliminate C. difficile leads to recurrent disease episodes
in ∼30% of patients (Johnson 2009). This fueled the investigation of fecal microbiota trans-
plantation (FMT) as an alternative treatment option, whereby patients are instilled with
healthy donor feces to replenish intestinal microbiota that prevent the growth of C. difficile.
FMT has shown impressive success rates of ∼90% against RCDIs and no severe adverse ef-
fects (Gough et al. 2011; Cammarota et al. 2014; O’Horo et al. 2014). A recent controlled
clinical trial demonstrated the superiority of FMT to antibiotics for RCDI treatment (van
Nood et al. 2013). FMT led to increased donor-like intestinal bacterial diversities within 2
wk (van Nood et al. 2013). Knowledge about the long-term effects of FMT, however, is pres-
ently not available. In addition, previous studiesmainly focused on bacteria. Because viruses,
especially phages, are the most abundant intestinal entities with the ability to influence mi-
crobial communities (Barr et al. 2013; Virgin 2014), they may well be relevant to C. difficile
infection and the microbial changes following FMT. This is also suggested by recent findings
that phages play a causative role in inflammatory bowel disease (IBD), which, similar to RCDI,
is characterized by pathologically altered gut microbiota (Norman et al. 2015).
We recently reported on a recovered RCDI patient whose fecal bacteria were of chimeric
composition of the patient and the healthy sister donor up to 7 mo post-FMT (Broecker et al.
2013), suggesting that stable attainment of intestinal microbial communitiesmay take longer
time periods. Here, we followed up this patient until 4.5 yr post-FMT, characterized fecal bac-
terial communities by 16S rRNA gene sequencing at various time points, and further ana-
lyzed previously reported viromes (Broecker et al. 2013) in comparison to the donor.
RESULTS
Patient History
Details on the patient history have been published (Broecker et al. 2013). Briefly, the female
patient was 51 years old when admitted to the University Hospital of Zurich with her sixth ep-
isode of RCDI, suffering from severe diarrhea and weight loss. Stool samples tested positive
for C. difficile by standard toxin A and B immunoassays, selective agar cultures, and agglu-
tination assays. The first episode of C. difficile infection occurred 2 yr before hospital admis-
sion after 7 mo of multiple antibiotic treatment against a complicated jawbone infection.
Multiple rounds of treatments against RCDI with the recommended antibiotics metroni-
dazole and vancomycin, partly in conjunction with the probiotic Saccharomyces cerevisiae,
were only temporally successful but lead to recurrence after cessation. A therapeutic trial
with intravenous immunoglobulins did not induce significant clinical responses. Finally,
FMT was performed with donor feces from the patient’s sister that tested negative for a va-
riety of bacterial and viral pathogens. A suspension of donor feces in sterile 0.9% sodium
chloride solution was applied intra-anally to the patient. Before the treatment, the patient
was given vancomycin to suppress growth of pathogenic C. difficile as well as loperamide
to prevent diarrhea. Following FMT, the patient reported changes in bowel movements
and intermittent obstipation, both of which ceased within 10 wk. Ever since, the patient
has remained free of symptoms for almost 5 yr now.
Bacterial Communities of the Patient Were Highly Variable up to 7 mo
Post-FMT and Similar to the Donor after 4.5 yr at the Phylum Level
A total of six fecal samples of the patient after FMT and the stool donor were collected
at various time points and subjected to 16S rRNA gene sequencing (Fig. 1A). The specimens
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included two long-term samples of the donor and the patient (D4 and P4, respectively),
both collected 4.5 yr post-FMT. Four additional samples, one donor sample at the time of
FMT (D0) and three patient samples 6–7mo after the treatment (P1–P3), have been previous-
ly analyzed by metagenomic sequencing (Broecker et al. 2013). In the present study, target-
ed 16S rRNA gene sequencing was also applied to the latter samples to make them
comparable to samples D4 and P4. A summary of the sequencing yields and accuracies is
provided in Table 1.
Taxonomic analysis of the donor samples at the time of FMT (D0) and 4.5 yr later
(D4) revealed bacterial communities dominated by the Bacteroidetes phylum (D0:
65% and D4: 83%), followed by Firmicutes (34% and 15%) (Fig. 1B). Remaining bacteria
accounted for <2% in these two samples. In contrast, the patient samples P1–P3 collected
6–7 mo post-FMT were mainly composed of up to 85% (P1) of phylum Firmicutes. In
this timespan, bacterial communities underwent extensive fluctuations. For instance,
Figure 1. Analysis of fecal microbiota. (A) Sample description. Fecal samples of the donor and the patient
were collected at the indicated time points and subjected to metagenomic and/or 16S rRNA gene sequenc-
ing. FMT, fecal microbiota therapy. (B) Bacterial compositions at the phylum level are shown as pie charts. The
inlay graph shows bacterial diversities inferred by Shannon indices as bars. (C ) Bacterial compositions at the
class, order, and family levels (from top to bottom) are shown as stacked bar graphs. Only taxa supported
by at least 1% of total reads at each level are shown. (D) Relative abundances of the five most dominant bac-
terial genera in samples D0, D4, and P4 are shown as bar graphs. Dialister and Faecalibacterium genera were
solely represented by the indicated species in each sample. The respective family names are given in paren-
theses. (E) Viral compositions of Caudovirales families are shown as pie charts.
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Bacteroidetes comprised 2% (P1), then 35% (P2), and finally 8% (P3) of all bacteria. The
phylum Chlamydiae, barely detectable in the donor, constituted up to 12% (P3) of the
patient’s bacteria. In contrast to P1–P3, the patient sample 4.5 yr post-FMT (P4) mainly
contained Bacteroidetes (77%) followed by Firmicutes (21%) and <2% remaining bacteria.
Bacterial diversities were estimated by calculating the Shannon diversity indices for all
samples at the species level. The Shannon indices showed a high degree of variability
even in the healthy donor, where an about twofold increase from the time point of FMT
(D0) to 4.5 yr afterward (D4) was observed (Fig. 1B). In the patient samples, a trend toward
increasing diversity from the time period covered by samples P1–P3 to 4.5 yr post-FMT
(P4) was observed that may, however, have been due to the fact that samples P1–P3 could
not be fully resolved down to the species level. At this time point, the bacterial diversities in
the samples from patient (P4) and donor (D4) were highly similar.
Bacterial Communities of the Patient Were Similar to Those
of the Donor after 4.5 yr up to the Order Level but Showed
Differences at Lower Taxonomic Levels
More detailed insights into the bacterial communities were gained at lower taxonomic levels.
In all six samples, bacteria of the Bacteroidetes phylum were exclusively assigned to the
order Bacteroidales (Bacteroidia class) (Fig. 1C). The Firmicutes phylum stratified into the
four orders Lactobacillales (Bacilli class), Clostridiales (Clostridia class), Erysipelotrichales
(Erysipelotrichia class), and Selenomonadales (Negativicutes class). At the order level, bac-
terial communities of D4 and P4 remained highly similar.
At the family level, some differences between these two samples became apparent. For
instance, the families Porphyromonadaceae and Rikenellaceae, both of the Bacteroidales
order as well as the Lachnospiraceae family of the Clostridiales order, were more abundant
in D4 than in P4.
Only samples D0, D4, and P4 were compared in more detail at the genus level, because
samples P1–P3 provided only full taxonomic information up to the family level. The relative
abundances of the five most dominant genera in samples D0, D4, and P4, including two that
were only represented by a single species, are shown in Figure 1D. Fractions of Bacteroides
spp., Dialister invisus, and Parabacteroides spp. were roughly similar between samples D4
and P4, whereas Alistipes spp. and Faecalibacterium prausnitzii were more abundant in
D4. Most interestingly, we did not identify any sequences assigned to C. difficile species
in any of the analyzed samples (data not shown).
Communities of dsDNA Viruses Were Variable and Consisted
Mainly of Caudovirales Phages
The analysis of viral dsDNA sequences reported earlier (Broecker et al. 2013) revealed the
presence of 22 viruses throughout samples D0, P1, P2, and P3 (Table 2). In each sample,
eight to 11 different viruses were identified, mainly belonging to the Caudovirales order
(tailed dsDNA phages) that contains the viral families Myo-, Podo-, and Siphoviridae. Most
viruses, 14 of 22, were identified uniquely in either sample. Three phages, the Erwinia phage
vB_EamP-L1 (Podoviridae) and the two Bacteroides phages B124-14 and B40-8
(Siphoviridae), were consistently detected in all four samples and each contained phages
of all three Caudovirales groups. Of these, Podoviridae were consistently most abundant.
Myo- and Siphoviridae showed highly variable abundances (Fig. 1E). The patient sample
P3 contained sequences related to the Paramecium bursaria Chlorella virus 1 (PBCV-1)
that infects eukaryotic algae (Table 2; Van Etten 2003).
Long-term human microbiota after fecal transplant
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DISCUSSION
FMT has been shown to be a promising treatment option for RCDI patients that leads to re-
plenishment of the patients’ gut microbiota through application of donor feces (Gough et al.
2011; van Nood et al. 2013; Cammarota et al. 2014; O’Horo et al. 2014). Here, we investi-
gated the long-term effects of FMT by analyzing fecal microbiota of a cured RCDI patient
in comparison to the donor until 4.5 yr after the procedure.
To analyze the bacterial compositions, we chose 16S rRNA gene sequencing using SMRT
(single-molecule real-time) sequencing on the Pacific Biosciences (PacBio) platform. Despite
its known limitations regarding raw read quality, this sequencing method has been success-
fully used previously to resolve compositions of microbial communities (Marshall et al. 2012;
Fichot and Norman 2013). In the present study, we used the latest chemistry (C6) that rein-
forces the main characteristics that make the PacBio platform attractive for microbial se-
quencing: the absence of sequence context-dependent error and GC-coverage biases
(Carneiro et al. 2012; Quail et al. 2012) and, most importantly, the read length. As shown
in Table 1, the generated reads were long enough to accurately cover full-length 16S
rDNA fragments through the application of the Reads of Insert protocol, an update of the
old circular consensus sequence (CCS). The resulting reads were first used as a query against
the Silva ribosomal RNA gene database (Quast et al. 2013) using the BLAST algorithm
(Altschul et al. 1990). Then, the MEGAN program (Huson et al. 2007) was used to build
Table 2. List of identified intestinal viruses
Virus
NCBI nucleotide
accession number
Genome
size (bp)
Number of
annotated
ORFs
Present
in D0?
Present
in P1?
Present
in P2?
Present
in P3?
Myoviridae Enterobacteria phage RB16 NC_014467.1 176,788 271 Yes Yes
Enterobacteria phage RB43 NC_007023.1 180,500 292 Yes Yes
Klebsiella phage KP15 NC_014036.1 174,436 258 Yes
Bacillus phage BCP78 NC_018860.1 156,176 227 Yes
Bacillus phage SP10 NC_019487.1 143,986 236 Yes
Streptococcus phage EJ-1 NC_005294.1 42,935 73 Yes
Podoviridae Erwinia phage vB_EamP-L1 NC_019510.1 39,282 51 Yes Yes Yes Yes
Escherichia phage TL-2011b NC_019445 44,784 57 Yes Yes Yes
Bacillus phage ϕ29 NC_011048 19,282 27 Yes
Siphoviridae Bacteroides phage B124-14 NC_016770 47,159 68 Yes Yes Yes Yes
Bacteroides phage B40-8 NC_011222 44,929 46 Yes Yes Yes Yes
Clostridium phage ϕCP34O NC_019508 38,309 52 yes
Lactococcus phage 936
sensu lato
KC182544 27,302 49 Yes
Lactococcus phage ϕ41 n.a. n.a. n.a. Yes
Listeria phage 2389 n.a. n.a. n.a. Yes
Listeria phage B025 NC_009812.1 42,653 65 Yes
Rhodococcus phage
ReqiPepy6
NC_023735 76,797 107 Yes
Unclassified
Caudovirales
Sinorhizobium phage PBC5 NC_003324 57,416 83 Yes Yes Yes
Unclassified
phages
Clostridium phage D-1873 n.a. n.a. n.a. Yes Yes
Tetrasphaera phage TJE1 NC_019930 49,219 66 Yes
Unclassified
dsDNA
viruses
Paramecium bursaria
Chlorella virus 1
NC_000852.5 330,611 802 Yes
Clostridium phage ϕSM101 NC_008265.1 38,092 53 Yes
NCBI, National Center for Biotechnology Information; ORFs, open reading frames; n.a., not available.
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taxonomic landscapes of the bacterial communities. This workflow has been successfully
used before to study microbial communities (Thomas et al. 2012; Li et al. 2013; Sharpton
2014) even of high diversity (Valverde and Mellado 2013). In the present study, both the
high-quality scores of the Reads of Insert of >99% and the mean number of passes of at least
15.4 indicated reliable sequencing results (Table 1).
The bacterial composition of the donor was relatively stable and comparable at the time
of FMT and 4.5 yr later (Fig. 1B), which is in accordance with the known temporal stability of
adult intestinal microbiota (Zoetendal et al. 1998). At the phylum level, Bacteroidetes were
most prominent, followed by Firmicutes, typical of healthy gut microbiota (Eckburg et al.
2005). The patient’s fecal microbiota underwent extensive compositional fluctuations and
were dominated by Firmicutes up to 7 mo post-FMT, suggesting ongoing adaptation pro-
cesses of donor microbiota in the patient’s intestine that may also reflect changes in nutrition
over the observation period. This is in accordance with our and other groups’ recent findings
that showed high degrees of bacterial variation in RCDI patients up to 7 mo post-FMT
(Broecker et al. 2013; Weingarden et al. 2015). However, 4.5 yr post-FMT, the patient’s bac-
teria have attained a donor-like composition at the phylum level, indicating full and stable
engraftment of the donor’s microbiota. The similarities between the donor’s and patient’s
bacterial compositions remained up to the order level (Fig. 1C). Differences observed at low-
er taxonomic levels might reflect host-dependent adaptation processes or temporal fluctu-
ations. Of note, four of the five most prominent genera identified in both donor samples as
well as the patient sample after 4.5 yr, Alistipes, Bacteroides,Dialister, and Faecalibacterium
(Fig. 1D), are known constituents of healthy fecal microbiota (Claesson et al. 2011; Joossens
et al. 2011). This further indicated that FMT led to healthy and sustainable microbiota in the
patient. Parabacteroides, another genus typical of healthy fecal microbiota (Claesson et al.
2011) was identified in both long-term samples but not in the donor at the time of FMT, per-
haps reflecting temporal fluctuations in the healthy donor. One notable species detected in
these three samples is Faecalibacterium prausnitzii (Fig. 1D). This species was also detected
in the patient samples 6–7 mo post-FMT with abundances of <0.1% (data not shown).
Faecalibacterium prausnitzii is recognized as one of the most important species of healthy
individuals and normally constitutes >5% of the gut microbiota (Miquel et al. 2013). Lower
than usual levels of F. prausnitzii have been associated with Crohn’s disease (Sokol et al.
2008; Joossens et al. 2011). The low abundance of F. prausnitzii in the samples of the present
study, especially of the patient, is intriguing. However, this may still reflect normal fluctua-
tions, as there have not been any symptoms of Crohn’s disease or other apparent complica-
tions in the patient.
The fact that the patient’s clinical symptoms, which included severe diarrhea in the ab-
sence of antibiotic treatment against C. difficile (Broecker et al. 2013), resolved promptly af-
ter FMT suggests that gut microbiota were able to exert normal metabolic functions even
before full engraftment. This may be explained by the fact that the patient’s bacterial diver-
sity even during the highly variable time period up to 7 mo post-FMT was already in the
range of the healthy donor. In agreement with the absence of symptoms until today, C. dif-
ficile bacteria were undetectable in the samples of the patient, similar to the donor who test-
ed negative for C. difficile before FMT (Broecker et al. 2013). This showed sustainable
elimination of C. difficile bacteria from the patient’s intestine and successful therapy on
the molecular level. It is worth mentioning that the patient had to undergo two short-term
antibiotic treatments for other indications with apparently no further consequences on the
gut microbiota. The finding that the patient’s fecal microbiota attained a highly donor-like
composition after 4.5 yr suggests that long-term follow-up should be implemented into clin-
ical practice. Moreover, this finding highlights the importance of selecting donor feces with a
healthy microbiota composition. An even better source material for FMT could be prospec-
tively freeze-stored own feces. The suitability of frozen feces for FMT has been demonstrated
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by a recent phase 1 clinical study, in which orally administered frozen capsules containing
healthy fecal matter cured 90% of RCDI patients (Youngster et al. 2014).
Viral sequences were identified by metagenomic sequencing from the same DNA prep-
arations thatwereused for 16S sequencing. Theanalysis of viral dsDNAsequences fromapre-
vious study (Broecker et al. 2013) revealed the presence of Caudovirales phages in all
investigated samples of the donor and the patient (Table 2). Caudovirales have been shown
before to be the dominant viruses in the human intestine, followed by ssDNA phages of
the Microviridae family that we were unable to detect with the metagenomic sequencing
approach (Lepage et al. 2008; Norman et al. 2015). Three phages were identified in all of
the analyzed samples of the donor and the patient. One is the Podovirus Erwinia phage
vB_EamP-L1 that infects Erwinia amylovora bacteria, the causal agent of fire blight in
Rosaceae species including apple and pear trees (Born et al. 2014). As its host, E. amylovora,
is not a normal constituent of intestinal microbiota, this phage was likely a food contaminant
that survived the stomach passage. The other two universally detected phages were the
Siphoviruses Bacteroides phages B124-14 and B40-8 that infect bacteria of the Bacteroides
genus abundantly found in the gut of healthy humans (Ogilvie et al. 2012). We detected
low and variable quantities of the Bacteroides genus in the patient 6–7mo post-FMT. In per-
cent of total reads, 0.3% (P1), 20.7% (P2), and 0.3% (P3) were assigned to Bacteroides (data
not shown). Even though 16S rRNA gene sequencing did not fully resolve the genus level in
these samples, they matched those of the Bacteroidaceae family that contained only
Bacteroides spp. in samples D0, D4, and P4 (Fig. 1C). In contrast to P1–P3, both donor sam-
ples showed high abundances (57.7% and 61.2%, D0 and D4, respectively) of Bacteroides
spp. similar to the patient sample 4.5 yr post-FMT (71.4%, P4) (Fig. 1D). The Bacteroides
phages may have been transferred from the donor to the patient where they could have
played a role in controlling Bacteroides populations during early stages through bacterial ly-
sis, as suggested before (Lepage et al. 2008; Ogilvie et al. 2012; Norman et al. 2015).
The replication of phages is dependent on the presence of their bacterial host.
Therefore, it is not surprising that we found extensive fluctuations in the virome when bacte-
ria were also highly variable in the patient’s samples up to 7 mo post-FMT. It has to be noted
that the viral abundances presented in Figure 1E were produced by the metagenomic se-
quencing approach in which viruses with higher gene numbers could be overrepresented
(Broecker et al. 2013). The Myoviridae may appear more abundant because of their larger
average genomes and gene numbers (Table 2). The relatively small Podoviridae were there-
fore the most dominant Caudovirales phages among all samples. Phages are known to be
able to regulate gut microbiota by bacterial lysis, horizontal gene transfer, and modulation
of the intestinal immune system (Barr et al. 2013; Virgin 2014). It is thus tempting to speculate
that they may have contributed to the bacterial population dynamics in the patient when the
gut microbiota have not yet been fully established.
The identification of PBCV-1-related sequences in one of the patient’s samples is intrigu-
ing because this virus has not yet been identified in the human intestine. PBCV-1 is a giant
virus that contains about 800 open reading frames (ORFs), 400 protein-coding genes,
and up to 16 tRNA genes. The related Acanthocystis turfacea Chlorella virus 1 (ATCV-1)
has been identified recently in human nasopharyngeal samples where its presence correlat-
ed with reduced cognitive function (Yolken et al. 2014), showing that giant viruses may well
be relevant for human health and disease. Sequences of Phycodnaviridae, the viral family
harboring PBCV-1 and ATCV-1, have previously been reported to be present in the intestine
of rodents (Phan et al. 2011). A possible role of PBCV-1 in the human intestine remains to be
elucidated, but its presence may simply have resulted from the intake of Chlorella algae–
contaminated freshwater (Van Etten 2003). The first identification of PBCV-1-related se-
quences in a human intestine, however, suggests that other unexpected viruses may be
detected in future studies.
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Phages are ∼10-fold more abundant than their prokaryotic hosts in the human gut where
they may influence bacterial diversity and population structure (Lepage et al. 2008; Minot
et al. 2013). The low number of eight to 11 phages identified per sample here may be an
underrepresentation, perhaps attributable to the DNA isolation procedure (Broecker et al.
2013). Also, the sequencing approach did not allow for distinguishing integrated prophages
from genomes of free virus particles (Broecker et al. 2013). The isolation of viral genetic
material from viral particles in stool supernatants may be more suitable to characterize fecal
virus communities (Lepage et al. 2008; Phan et al. 2011; Norman et al. 2015). It has been
reported that phages in the gut may be liberated under pathologic conditions, like inflam-
mation (Lepage et al. 2008), suggesting that low numbers may correlate with healthy gut
microbiota.
Overall, our findings demonstrate the long-term efficacy of FMT for the treatment of
RCDI on the molecular level. Highly diverse phage communities suggest a possible role
of phages during engraftment of donor microbiota. In light of a recent study that showed
a causative role of phages in the etiology of IBD (Norman et al. 2015), gut viruses may be
relevant during C. difficile disease and response to FMT as well. This is the subject of ongo-
ing comprehensive investigations of fecal viromes of RCDI and IBD patients treated with
FMT at the University Hospital and the ETH Zurich.
METHODS
Metagenomic Sequencing
The metagenomic-sequencing data used to characterize viruses in samples D0, P1, P2, and
P3 (Table 1) is from a previous publication (Broecker et al. 2013). Briefly, DNA was isolated
from ∼0.2 g of frozen-stool samples with the QIAamp DNA Stool Mini Kit (QIAGEN), then
treated with DNase-free RNase (Fermentas), and further purified by phenol/chloroform ex-
traction. Barcoded libraries were generated with the NEBNext DNA sample prep kit (New
England Biolabs) and sequenced on an Illumina Genome Analyzer IIx instrument in a 120-
base paired-end multiplex run. Read sets were assembled to contiguous sequences with
the CLC Genomic Workbench V5. ORFs of these contigs were predicted with GLIMMER3
(Salzberg et al. 1998). The ORFs were queried in the NR-PROT protein database (Benson
et al. 2009) using BLASTP (Altschul et al. 1990). The first listed protein hit of each ORF
was taxonomically assigned using MEGAN. For more details, refer to Broecker et al. (2013).
16S rRNA Gene Sequencing
Fecal DNA was isolated as described above in “Metagenomic Sequencing.” For samples
D0, P1, P2, and P3, the same DNA preparations used previously for metagenomic sequenc-
ing (Broecker et al. 2013) and stored at−80°Cwere subjected to 16S rRNAgene sequencing.
A broad-range 16S rDNA PCRwas performedwith the Phusion High-Fidelity PCRMasterMix
(Finnzymes/NEB), using universal primers TPU-1 (AGAGTTTGATCMTGGCTCAG), 1387r
(GGGCGGWGTGTACAAGGC), and one-tenth of primer Bif-8F (AGGGTTCGATTCTGGCT
CAG) in order to amplify ∼1300 bp of the bacterial 16S rRNA genes. PCR cycling conditions
were 3 min at 98°C (10 sec at 98°C 30 sec at 55°C, 45 sec at 72°C) × 24; 10 min at 72°C).
Sequencing on the PacBio RS II was performed with SMRT cell libraries prepared with the
DNA Template Prep Kit 2.0 (250 bp to <3 kb) (Pacific Biosciences p/n 001-540-726) and
1400-bp selected target size. Consensus sequences were generated with the Reads of
Insert protocol by retaining only sequences with ≥90% accuracy and 1400 ± 100 bp length.
The minimum number of passes was set to 3. A summary of the sequencing yields and ac-
curacies is provided in Table 1.
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Phylogenetic Analysis of 16S rRNA Gene Sequencing Data
Resulting Reads of Insert consensus sequences were analyzed in the release 115 of the SILVA
database (Quast et al. 2013) using v2.2.29 of BLAST (Altschul et al. 1990). An e-value of 0.001
was imposed as threshold and 100 sequences were retained (‘-evalue 0.001 -max_target_
seqs 100’). Output from the BLAST alignment was analyzed with v5.0 of the MEGAN pro-
gram (Huson et al. 2007) with a threshold of at least five supporting reads for a taxonomic
level to be reported as present. Bacterial diversities at the species level have been estimated
by calculating Shannon indices (Etter 1999).
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